Chinese firm copycats Gilead's remdesivir, the most promising drug against the new coronavirus

Gilead's experimental remdesivir has emerged as the most promising candidate against the deadly new coronavirus. But some unexpected confusion has cropped up about its China patent—the latest being a Chinese firm claiming it's successfully copied the drug and started mass production.